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Abstract 
The purpose of the given paper is to analyze blood clots (BCs) by using Artificial 
Neural Network (ANN) using the physical symptoms as the input data.  Such a NN 
provides an analytical alternative to conventional techniques, and allows the user to 
model BCs. Sensor Data application provides direct access to data.  All the data have 
been collected by using different types of sensors. Based on the symptoms these sensors 
can pass the data (offline or in real time) to the NN, where the latter will analyze it 
though a modelling system designed to distinguish the blood clotting. This paper 
illustrates the effect of using a combination of different types of sensors. These sensors 
will provide inputs to a well-designed NN that aims to model the BC, and analyse it in a 
way that gives better predictions of the presence of a BC or at least an early warning 
indicating BC presence.  By using this model, developed in the given paper, the patients 
will be able to predefine danger of occurrence of blood clotting. 
 
Keywords: artificial neural network model, blood clotting prediction, sensor 
measurement. 
1. Introduction 
Brain is the control center of the body. It controls thoughts, memory, speech and movement. 
It regulates the function of many organs. When the brain is healthy, it works efficiently and 
automatically. However, when disorders occur, the results can be devastating. One of the common 
disorder of brain is stroke also called brain attack (a medical emergency). Stroke is a major cause of 
death and disability in both the developed and the less developed countries [1] [2].Stroke consumes 
an important part of the total healthcare costs (i.e. excluding social care and indirect costs) in 
Europe and USA [3]. 
The World Health Organization reports that 15 million people worldwide suffer stroke; and of 
these, 5 million die and a further 5 million are left permanently disabled, many severely impaired. 
Consequently stroke is a major cause of mortality world-wide. Most strokes are caused by a blood 
clot that occludes an artery in the cerebral circulation. Thrombolytic agents such as Alteplase are 
used to dissolve blood clots that arise in the cerebral arteries of the brain but there are limitations on 
their use. Recently screening for patients at risk of strokes and TIA’s has come into being. If such 
plaques are detected in the carotid arteries (by Ultrasound), a Carotid endarterectomy (CEA) - a 
surgical operation - may be performed to remove the occlusive plaque. 
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Blood clots form as a result of the coagulation of blood. A blood clot that forms in a vessel or 
the heart and stays in the location it formed is called a thrombus. A blood clot that leaves the area of 
its formation is known as an embolus/embolism (disorder). Thrombi or emboli may attach to a 
blood vessel and partially or completely block the flow of blood in that vessel. Blockage that 
prevents normal blood flow and proper intake of oxygen is referred to as ischemia. If not treated 
quickly, damage or death (infarction or necrosis) of the tissues in that area occurs [4-6]. One of the 
most common forms of blood clot disorders is deep venous thrombosis. It is speculated that there 
are approximately 3 million cases per year in the United States [4-6]. While not necessarily a 
reliable number, this still indicates that blood clot disorders occur in a very large portion of the US 
population each year.  
There are a diverse range of diagnostic techniques available to physicians when a blood clot is 
suspected. These include but are not limited to duplex ultrasound, magnetic resonance imaging, 
venography, computed tomography scans, magnetic resonance angiography, D-Dimer test, 
arteriography/angiography, and impedance plethysmography. These techniques differ in the method 
they employ to determine the existence of a blood clot, and are also designed specifically to detect 
different disorders.   
Early detection of blood clots was studied using neural network models [8 -11, 12-14], 
statistical models [15, 16, 17], genetic algorithms [18], and other machine learning techniques 
including decision tree, fuzzy sets, and evolutionary algorithms. The models used on practical study 
of patients, for the early diagnosis of myocardial infarction, chest pain, heart attack, develop the 
statistical models on available data, and on available practical issues associated with the realization 
of a cardiac functions. Most of the information on Web available are the physical symptoms for 
blood clots. But none of these symptoms are used to make a tool useful for the average citizen. For 
every suspected case, doctors run a number of tests and spend enormous amounts of money before 
they ascertain the real cause. We feel a simple device developed as an outcome of the research to 
predict the symptoms of blood clot will help many people to avoid the deaths happening today. The 
current research is based on developing an inexpensive tool to detect blood clots in patients 
suffering from headache and other symptoms. 
Over the past decade, other methods of treatment have been developed which include 
Thrombectomy Devices e.g. the ‘GP’ Thrombus Aspiration Device GPTAD - fig. 1) [19]. Such 
devices have the potential to be used as an alternative to thrombolytic agents or in conjunction with 
them to extract clots in different arteries e.g. in the middle cerebral artery of the brain, carotid, 
popliteal artery, etc. A clot of blood may also become attached to the plaque (deposition of fats and 
lipids that may arise within arteries) in a distal artery, and subsequently become detached and travel 
to the cerebral circulation giving rise to a stroke. In the case of 100% occlusion, it causes total 




Some catheter diameters and distances between the GPTAD device and the blood clot are 
compared for a 95% occlusion to highlight differences between these situations. This level of 
occlusion has been selected since many thrombosis that occur in arteries exhibit this high level of 
occlusion by blood clots. In cases with a low occlusion, the GPTAD would not be useful, since 
blood would be sucked principally instead of extracting the clot. 
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2. Neural Network description 
One type of network sees the nodes as ‘artificial neurons’. These are called artificial neural 
networks (ANNs). An artificial neuron is a computational model inspired in the natural neurons. 
Natural neurons receive signals through synapses located on the dendrites or membrane of the 
neuron. When the signals received are strong enough (surpass a certain threshold), the neuron is 
activated and emits a signal though the axon. This signal might be sent to another synapse, and 




Neural networks (NN) are inspired by nervous systems found in biological organisms. A 
neural network is designed to capture relationships among dependent and independent variables in a 
given sample data set. Unlike parametric models used in statistical techniques, ANN does not 
require any restrictive a priori assumptions about the relationship among independent and 
dependent variables [6]. In addition, they are adaptive and can respond to structural changes in the 
data generation process in ways that parametric models cannot. An ANN consists of a number of 
connected nodes each of which is capable of responding to input signals with an output signal in a 
predefined way. These nodes are ordered in layers. A network consists of one input layer, one 
output layer, and an arbitrary number of hidden layers in between. 
The backpropagation algorithm (Rumelhart and McClelland, 1986) is used in 
layered feed-forward ANNs. This means that the artificial neurons are organized in layers, 
and send their signals “forward”, and then the errors are propagated backwards. The network 
receives inputs by neurons in the input layer, and the output of the network is given by the neurons 
on an output layer. There may be one or more intermediate hidden layers. 
The backpropagation algorithm uses supervised learning, which means that we provide the 
algorithm with examples of the inputs and outputs we want the network to compute, and then the 
error (difference between actual and expected results) is calculated. The idea of the backpropagation 
algorithm is to reduce this error, until the ANN learns the training data. The training begins with 
random weights, and the goal is to adjust them so that the error will be minimal. 
The activation function of the artificial neurons in ANNs implementing the  backpropagation 
algorithm is a weighted sum (the sum of the inputs xi multiplied by their respective weights     wji) : 
 
                                                    (1) 
 
 
All connections are assigned a weight (a real number). The training or learning of the network 
occurs through the introduction of cycles of data patterns (epochs or iterations) to the network. One 
problem with neural network training is the tendency of the network to memorize the training data 
after an extended learning phase. If the network over learns the training data it is more difficult for 
the network to generalize to a data set that was not seen by the network during training. 
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Therefore, it is common practice to divide the data set into a learning data set that is used to 
train the network and a validation data set that is used to test network performance. 
In medical practice, ANNs are generally used to diagnose and monitor the  prognosis of a 
disease. ANNs have been used to determine prognosis in trauma, prognosis after cardiopulmonary 
resuscitation, outcome of treatment for ovarian cancer, prognosis in acquired immunodeficiency 
syndrome (AIDS), predicting mortality of patients with endstage liver disease, prognosis for 
patients with colonic cancer, detecting extensive coronary artery disease, predicting length of stay 
in the intensive care unit following cardiac surgery and predicting the risk of death for small-cell 
lung cancer patients.  
3. Model of the Neural Network for blood clots 
The model created in this paper is a BP neural network model with 10 inputs which are 
combination of symptoms and risk factors of blood clots provided by the patients.The presence of 
symptom and risk factor is 1 and absence is 0.In this model single hidden layer has been used. 
Output layer consists of one node whichrepresents the probability of occurrence of blood clots. 
3.1 Input layer 
The input layer of a neural network is determined from the characteristics of the application 
input. For prognosis of blood clotting we used 10 inputs which are combination of symptoms and 
risks factors. Following symptoms and risk factors are the input to the neural network: 
 
S1 Sudden numbness or weakness of face, arm or leg, often one side of the body. 
S2 Sudden confusion, trouble speaking or understanding. 
S3 Sudden trouble seeing in one or both eyes. 
S4 Sudden trouble walking, dizziness loss of balance or coordination. 
S5 Sudden severe headache with no known cause. 
R6 High blood pressure 
R7 Diabetes 
R8 Transitory ischemic attack 
R9 Stenos carotid artery 
R10 Smoking 
3.2 Hidden layer 
Hidden layer automatically extracts the features of the input and reduces its dimensionality 
further [6]. There is no specific rule that dictates the number of hidden layers. Usually, one hidden 
layer is used. The reason for this is that one hidden layer is sufficient to approximate any continuous 
function to an arbitrary precision. In this model we chose one hidden layer with 20 neurons & 
logistic sigmoid functions. 
3.3 Output Layer 
We can predict the presence or absent of blood clots based on the output of the neural 
network. So if output is 1 blood clotting is present & if it is 0 blood cloting is absent. We assume 
that the actual output of the neuron in the output layer is yj(t) at time t and the expected output dj(t), 
so the network error function E(t) at the time t will be defined as follows: q is the number of 
neurons in the output layer and is one for this neural network; ε is a pre-set error margin.  
                                                                                                   
                                       (20) 
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4. Sensor Measurement 
Sensor Data application provides direct access to data.  All the data have been collected by 
using different types of sensors. Based on the symptoms these sensors can pass the data (offline or 
in real time) to the NN, where the latter will analyze it though a modelling system designed to 
distinguish the blood clotting. The  method based on magnetoelastic sensors has been used for the 
monitoring of blood coagulation. The ribbon-like magnetoelastic sensor oscillates at a fundamental 
frequency, which shifts linearly in response to applied mass loads or a fixed mass load of changing 
elasticity. The magnetoelastic sensors emit magnetic flux, which can be detected by a remotely 
located pick-up coil, so that no direct physical connections are required. During blood coagulation, 
the viscosity of blood changes due to the formation of a soft fibrin clot. 
5. Conclusion 
In the given paper, ANN based model has been used to develop a system in which patients 
would be able to self-diagnose themselves Before visiting a doctor. Prognosis of early diagnosis of 
blood clots with ANN models has the best performance in large data sets. MATLAB program was 
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developed to model and train NN. The ‘nftool' were used to diagnose the symptoms. The ‘nftool’ 
proved to be the most effective due to its higher percent correlation. 
References 
A. Fiez et al. "Lesion Segmentation and Manual Warping to a Reference Brain: Intra- and 
Interobserver Reliability”. Human Brain Mapping 2000, vol. 9, pp.192–211. 
1. C L M. Sudlow et al. “Comparable studies of the incidence of stroke and its pathological 
types. Results from an international collaboration”. Stroke 1997, vol. 28(3), pp.491–499. 
2. M. Evers et al. “Economic evaluation in stroke research”. J Cerebrovasc Dis 2000, vol.11, 
pp. 82–91. M. Astion, P. Wilding, “The Application of backpropagation neural networks to 
problems in pathology and laboratory medicine”, Arch. Pathol. Lab. Med., 116, 995-1001, 
1992. 
3. D. Schreiber, “Deep Venous Thrombosis and Thrombophlebitis”, 2005, 
http://www.emedicine.com/EMERG/topic122.htm 
4. F. Arnaldo, “Arterial Embolism”, 2004,  
http://www.nlm.nih.gov/medlineplus/ency/article/001102.htm  
5. M. H. Beers, A. J. Fletcher, M. B, BChir, T. V Jones, M. P. H. Porter, M. Berkwits, J. L. 
Kaplan, eds. “Superficial Thrombophlebitis”, 2003, 
http://www.merck.com/mmhe/sec03/ch036/ch036c.html 
6. Leon Sanders and Y.B. Reddy. Detecting Blood Clots using Neural Networks. 
7. W. G. Baxt, F. S. Shofer, F. D. Sites, J. E. Hollander, “A neural network aid for the early 
diagnosis of cardiac ischemia in patients presenting to the emergency department with chest 
pain”, Ann Emerg Med. 40, pp 575–583, 2002. 
8. W. G. Baxt, F. S. Shofer, F. D. Sites, J. E. Hollander, “A neural computational aid to the 
diagnosis of acute myocardial infarction”, Ann Emerg Med. 2002. 
9. R. L. Kennedy, A. M. Burton, H. S. Fraser, L. N. McStay, R. F. Harrison, “Early diagnosis 
of acute myocardial infarction using clinical and electrocardiographic data at presentation: 
Derivation and evaluation of logistic regression models”, Eur Heart J. 17, pp 1181–1191, 
1996. 
10. R. L. Kennedy, R. F. Harrison, A. M. Burton, H. S. Fraser, W. G. Hamer, D. MacArthur, R. 
McAllum, D. J. Steedman, “An artificial neural network system for diagnosis of acute 
myocardial infarction (AMI) in the accident and emergency department: Evaluation and 
comparison with serum myoglobin measurements”, Comput Methods Programs Biomed. 52, 
pp 93–103, 1997. 
11. M. Astion, P. Wilding, “The Application of back-propagation neural networks to problems 
in pathology and laboratory medicine”, Arch. Pathol. Lab. Med., 116, 995- 1001, 1992. 
12. M. L. Astion, M.H. Wener, R.G.Thomas, G.Hunder, D.A. Bloch, “Overtraining in neural 
networks that interpret clinical data”, Clin. Chem. 39, 1998-2004, 1993. 
13. J. W. Furlong, M.E. Dupuy, J.A.Heinsimer, “Neural network analysis of serial cardiac 
enzyme data”, Am. J. Clin. Pathol. 96, 134-141, 1991. 
14. Liu, Tiepu, Wang, Qiong, Baxter, M Stephen, Sayre, Michael R, Gibler, W Brian, 
“Development of a statistical model for prediction of acute myocardial infarction by 
biochemical markers”, Drug Information Journal, Jan-Mar 1999. 
15. R. L. Kennedy, R. F. Harrison, “Identification of patients with evolving coronary syndromes 
using statistical models with data from the time of presentation”, Heart, 92(2), pp 83-89, 
2006. 
GESJ: Computer Science and Telecommunications 2014|No.3(43) 
ISSN 1512-1232 
 
    66
16. O. Aase, J. Jonsbu, K. Liestol, A. Rollag, J. Erikssen, ”Decision support by computer 
analysis of selected case history variables in the emergency room among patients with acute 
chest pain”, Eur Heart J. 14, pp 433–440, 1993. 
17. Z. Syed, E. Vigmond, S. Nattel and L. J. Leon, “Atrial cell action potential parameter fitting 
using genetic algorithms”, Jr Medical and Biological Engineering and Computing, Springer 
Berlin / Heidelberg, ISSN 0140-0118, Volume 43, Number 5 / October, 2005. 
18. Pearce G, Perkinson ND (2006) “Biomechanical Probe”. International Patent Corporate 
Treatise (WO2006120464) published 2006-11-16 ; European patent (EP1893195 (A2)) 
published 2008-03-05; Japanese patent (JP2008639924 (T)) Published 2008-11-20; Chinese 







Article received: 2014-09-16 
 
 
 
